Nicardipine in heart failure: Distinguishing its acute beneficial from its chronic effects

J. Sy, A. Vitarelli*, M. Gheorghiade

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Concern over negative inotropic effects has limited the use of calcium blockers in patients with congestive heart failure. Nicardipine, a second generation dihydropyridine calcium channel blocker, has demonstrated positive hemodynamic effects in short-term therapy in patients with congestive heart failure. Prolonged use of calcium channel blockers remains contraindicated in patients with congestive heart failure due to the potential for activation of the renin-angiotensin system. However, acute intravenous nicardipine administration has important clinical applications (as in the management of surgical hypertension or hypertensive emergencies). Nicardipine may be safely used for these indications even in the presence of congestive heart failure.

Original languageEnglish (US)
Pages (from-to)535-541
Number of pages7
JournalMinerva Cardioangiologica
Volume41
Issue number11
StatePublished - Dec 1 1993

Keywords

  • heart failure, congestive
  • nicardipine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Nicardipine in heart failure: Distinguishing its acute beneficial from its chronic effects'. Together they form a unique fingerprint.

Cite this